神經調節設備市場規模、佔有率、成長分析、按產品、按應用、按最終用途、按地區 - 按行業預測，2024-2031 年

2022年神經調節劑的全球市場規模估值為51.3億美元，從2023年的55.8億美元成長到2031年的108.7億美元，預計在預測期內（2024-2031年）將以複合年成長率成長。

由於慢性病的盛行率不斷增加以及這些疾病的藥物治療的局限性，神經調節劑市場正在迅速擴大。對人類神經功能特性和電刺激效果的廣泛研究推動了神經調節技術的進步。用於控制疼痛的脊髓刺激和用於治療癲癇的迷走神經刺激等創新療法正變得越來越普遍，凸顯了標靶治療的演變。對神經退化性疾病的認知不斷提高以及神經調節應用開發的進步是關鍵的成長動力。然而，高營運成本和缺乏技術純熟勞工等挑戰可能會阻礙預測期內的市場擴張，需要採取策略性方法來解決這些障礙。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析及影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

神經調節劑市場規模：依產品分類

• 市場概況
• 脊髓刺激設備
• 深層腦部刺激器
• 薦骨神經刺激器
• 迷走神經刺激設備
• 胃電刺激
• 其他

神經調節劑市場規模：依應用分類

• 市場概況
• 帕金森氏症
• 慢性疼痛
• 癲癇
• 偏頭痛
• 尿失禁和大便失禁
• 發抖
• 憂鬱症
• 其他

神經調節劑市場規模：依最終用途分類

• 市場概況
• 醫院和門診手術中心 (ASC)
• 診所和物理治療中心
• 其他

按地區分類的神經調節劑市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Medtronic
• Synapse Biomedical
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• Nevro Corp.
• NeuroSigma Inc.
• NeuroPace Inc.
• Cyberonics Inc.
• NDI Medical LLC
• NeuroMetrix Inc.
• NeuroVista Corporation
• Neuronetics Inc.
• BioControl Medical
• SPR Therapeutics
• MicroTransponder Inc.
• Soterix Medical Inc.
• BrainsWay Ltd.
• Saluda Medical Pty Ltd

結論和建議

Global Neuromodulation Devices Market size was valued at USD 5.13 billion in 2022 and is poised to grow from USD 5.58 billion in 2023 to USD 10.87 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The neurostimulation market is expanding rapidly due to the increasing prevalence of chronic conditions and the limitations of pharmaceutical treatments for these diseases. Advances in neurostimulation techniques have been driven by extensive research into the functional properties of human nerves and the effects of electrical stimulation. Innovative treatments, such as spinal cord stimulation for pain management and vagus nerve stimulation for epilepsy, are gaining traction, highlighting the evolution of targeted therapies. The surge in awareness of neurodegenerative diseases and ongoing developments in neuromodulation applications are key growth drivers. However, challenges such as high operational costs and a shortage of skilled workforce may impede market expansion during the forecast period, necessitating strategic approaches to address these hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuromodulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuromodulation Devices Market Segmental Analysis

Global Neuromodulation Devices Market is segmented by Product, Application, End-use, and region. Based on Product, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electrical Stimulation, Others. Based on Application, the market is segmented into Parkinson's Disease, Chronic Pain, Epilepsy, Migraine, Urinary & Faecal Incontinence, Tremor, Depression, Others. Based on End-use, the market is segmented into Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuromodulation Devices Market

The global neuromodulation devices market is influenced by several driving factors. A significant contributor to the market's growth is the rising prevalence of health concerns among diverse populations. Neuromodulation devices have gained popularity as effective solutions for managing chronic pain, including conditions such as shoulder pain, headaches, and brain injuries, showcasing their remarkable ability to provide relief across a spectrum of ailments. Furthermore, these devices are increasingly utilized for treating mental health issues, digestive disorders, and sleep-related problems. Consequently, the expanding adoption of neuromodulation technology for addressing a wide range of health conditions is significantly propelling the market forward.

Restraints in the Global Neuromodulation Devices Market

The global neuromodulation devices market faces significant obstacles stemming from several factors. Primarily, the substantial capital investment required poses a considerable barrier to entry, making it difficult for emerging players to establish themselves in the industry. Additionally, the high production costs associated with manufacturing neuromodulation devices further exacerbate this challenge, restricting market growth. Furthermore, the market is impeded by a shortage of skilled professionals, as effective utilization of these devices necessitates expertise and specialized training. This lack of qualified personnel hampers the broader adoption and implementation of neuromodulation therapies, ultimately constraining market expansion.

Market Trends of the Global Neuromodulation Devices Market

The Global Neuromodulation Devices market is experiencing significant growth, driven by an increasing number of patients with chronic conditions such as back pain, depression, epilepsy, and sleep apnea exhibiting resistance to traditional drug therapies. This shift towards neurostimulation methods reflects a proactive response from healthcare practitioners who are seeking more effective solutions for slow-progressing treatments and inadequate outcomes. As the demand for alternative management strategies grows, neuromodulation devices are being increasingly recognized for their potential to enhance patient quality of life, thus propel market expansion, ensuring a promising future for innovative therapeutic approaches in chronic disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Neuromodulation Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electrical Stimulation
• Others

Global Neuromodulation Devices Market Size by Application & CAGR (2024-2031)

• Market Overview
• Parkinson's Disease
• Chronic Pain
• Epilepsy
• Migraine
• Urinary & Faecal Incontinence
• Tremor
• Depression
• Others

Global Neuromodulation Devices Market Size by End-use & CAGR (2024-2031)

• Market Overview
• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others

Global Neuromodulation Devices Market Size & CAGR (2024-2031)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NDI Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroVista Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainsWay Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation